The Department of Defense issued just over $1.5 billion worth of new contracts Monday. A little more than $600 million of these were for bulk orders of fuel. However, a few traditional defense contractors (and a few less traditional contractors) also booked wins. Notably:
Northrop Grumman won a $6.7 million contract modification to upgrade LOW VHF antennas and Black Wideband Relays on two E-11A communications relay aircraft and two EQ-4B pilotless, Global Hawk-based comms aircraft. This work should be complete by June 23, 2014.
Rolls-Royce was awarded $7.1 million to supply engineering services to maintain 9,253 hours' worth of flight time (through November 2013) on Navy MV-22 tiltrotor aircraft in support of Operation Enduring Freedom and of Marine Expeditionary Units deployments.
Raytheon won a $10 million contract to perform design work on, and begin building a prototype of, the Joint Miniature Munitions Bomb Rack Unit (JMM BRU) for the U.S. Air Force. The JMM BRU is intended to create a bomb carriage for attaching four 250-lb. small-diameter bombs to an aircraft.
American Apparel was awarded an option exercise on a contract to supply up to $15 million worth of U.S. Marine Corps combat utility uniform blouses through June 27, 2014.
AstraZeneca subsidiary MedImmune Biologics won a maximum $23.3 million firm-fixed-price, sole-source contract to supply influenza vaccine doses deliverable by nasal spray to the U.S. Army, Navy, Air Force, and Marine Corps by June 25, 2014.
The article $1.5 Billion in DoD Contracts Includes Flu Vaccines and New Shirts originally appeared on Fool.com.
Fool contributor Rich Smith has no position in any stocks mentioned. The Motley Fool owns shares of Northrop Grumman and Raytheon Company. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.